Kiromic Biopharma, Inc. Operating Lease, Expense
Kiromic Biopharma, Inc. reported Operating Lease, Expense of $716.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-02-14
- Kiromic Biopharma, Inc. operating lease, expense for the quarter ending 2024-12-31 was $179.00K, a 0.00% change year-over-year.
- Kiromic Biopharma, Inc. operating lease, expense for the quarter ending 2024-09-30 was $179.00K, a 0.00% change year-over-year.
- Kiromic Biopharma, Inc. operating lease, expense for the quarter ending 2024-06-30 was $179.00K, a 0.56% decline year-over-year.
- Kiromic Biopharma, Inc. operating lease, expense for the quarter ending 2024-03-31 was $154.00K, a 16.67% increase year-over-year.
- Kiromic Biopharma, Inc. operating lease, expense for fiscal 2024 was $716.00K, a 0.00% change from fiscal 2023.
- Kiromic Biopharma, Inc. operating lease, expense for fiscal 2023 was $716.00K, a 81.63% increase from fiscal 2022.
- Kiromic Biopharma, Inc. operating lease, expense for fiscal 2022 was $394.20K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $358.00K derived: sum of 2 quarters · filed 2025-02-14 | $537.00K derived: sum of 3 quarters · filed 2025-02-14 | $716.00K 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | $179.00K 10-Q · filed 2024-11-08 | $358.00K derived: sum of 2 quarters · filed 2024-11-08 | $537.00K 10-Q · filed 2024-11-08 | $691.00K derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | $179.00K 10-Q · filed 2024-08-09 | $358.00K 10-Q · filed 2024-08-09 | $512.00K derived: sum of 3 quarters · filed 2025-02-14 | $691.00K derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | $154.00K 10-Q · filed 2024-05-10 | $333.00K derived: sum of 2 quarters · filed 2025-02-14 | $512.00K derived: sum of 3 quarters · filed 2025-02-14 | $692.00K derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $358.00K derived: sum of 2 quarters · filed 2025-02-14 | $538.00K derived: sum of 3 quarters · filed 2025-02-14 | $716.00K 10-K · filed 2025-02-14 | $574.80K 10-K · filed 2024-03-19 | |||
| 2023-09-30 | $179.00K 10-Q · filed 2024-11-08 | $359.00K derived: sum of 2 quarters · filed 2024-11-08 | $537.00K 10-Q · filed 2024-11-08 | $424.50K 10-Q · filed 2023-11-14 | $612.20K derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $180.00K 10-Q · filed 2024-08-09 | $358.00K 10-Q · filed 2024-08-09 | $276.90K 10-Q · filed 2023-08-14 | $433.20K derived: sum of 3 quarters · filed 2024-08-09 | $567.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $132.00K 10-Q · filed 2024-05-10 | $131.50K 10-Q · filed 2023-05-15 | $253.20K derived: sum of 2 quarters · filed 2024-05-10 | $387.00K derived: sum of 3 quarters · filed 2024-05-10 | $375.80K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $121.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $255.00K derived: sum of 2 quarters · filed 2024-03-19 | $243.80K derived: sum of 3 quarters · filed 2024-03-19 | $394.20K 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $133.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $122.60K derived: sum of 2 quarters · filed 2023-11-14 | $273.00K 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$11.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $139.20K 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $150.40K 10-Q · filed 2023-05-15 |